Market Correction Enters Key Phase; Analysts See Stock-Specific Opportunities Despite Near-Term Volatility

The Indian stock market is approaching a critical technical juncture as the Nifty 50 hovers near important support levels following a sharp pullback from recent highs. According to analysts at HDFC Securities, the benchmark index is currently testing a strong support cluster that could determine the market's next major move.

After failing to sustain above the crucial resistance zone near 24,190, the Nifty slipped below immediate support levels, prompting caution among traders. However, technical indicators suggest that the broader market structure remains positive as long as key support zones continue to hold.

Amid the ongoing consolidation, HDFC Securities has highlighted two stocks—Gland Pharma and Viyash Scientific—that are showing strong bullish chart patterns and could outperform in the coming weeks.

Nifty Faces a Critical Technical Test

The benchmark Nifty 50 recently witnessed profit-booking after a strong rally, leading to a decline below the immediate swing low of 23,901.

Technical analysts note that the index has now entered an important support area formed by a combination of moving averages, Fibonacci retracement levels, and an unfilled price gap created during the recent uptrend.

The Nifty closed near its 50-Day Exponential Moving Average (DEMA), which many market participants consider a significant technical indicator for assessing medium-term market direction.

Key Levels Traders Are Watching

According to HDFC Securities, several technical indicators converge around the current trading range:

• 20-Day EMA near 23,750

• 50-Day DEMA near 23,825

• Gap support zone between 23,645 and 23,817

• 38.2% Fibonacci retracement at 23,761

• 50% Fibonacci retracement at 23,630

The alignment of multiple support indicators in the same region creates a strong technical base for the index.

Why the 23,630–23,800 Zone Matters

Market experts often view clusters of support levels as zones where institutional buying may emerge.

The current support range has gained importance because it combines historical price support, moving averages, and retracement levels from the previous rally.

If buyers successfully defend this zone, the Nifty could resume its upward trajectory and attempt to reclaim the 24,000 mark.

However, a decisive breakdown below 23,630 could increase selling pressure and trigger a deeper correction.

Downside Risk Remains Limited for Now

Should the support zone fail, analysts see the next significant support level around 23,500, corresponding to the 61.8% Fibonacci retracement level of the previous rally.

Despite this possibility, the broader market trend remains constructive as long as the index continues to trade above major long-term moving averages.

Market Sentiment Supported by Strong Domestic Fundamentals

While technical factors dominate short-term market movements, the medium-term outlook continues to be supported by favorable macroeconomic conditions.

India remains one of the fastest-growing major economies globally, with robust domestic consumption, improving corporate earnings visibility, and sustained infrastructure spending supporting investor confidence.

Foreign institutional investor flows have also shown signs of stabilization, while domestic mutual fund inflows continue to provide resilience during market corrections.

Key Drivers Supporting the Market

• Strong GDP growth outlook

• Rising retail participation

• Continued SIP inflows

• Stable banking system

• Government infrastructure spending

• Healthy corporate balance sheets

These factors continue to provide a supportive backdrop for Indian equities despite periodic corrections.

Gland Pharma Emerges as a Strong Technical Breakout Candidate

CMP: ₹2,290

Target: ₹2,500

Stop Loss: ₹2,150

Among the stocks highlighted by HDFC Securities, Gland Pharma stands out due to a combination of strong chart patterns and improving momentum indicators.

The pharmaceutical company's stock has reportedly broken out from a bullish inverted head-and-shoulders pattern on the monthly chart, which is widely regarded as one of the most reliable reversal formations in technical analysis.

In addition, the stock has also confirmed a breakout from a bullish flag pattern on the daily chart, signaling a continuation of the prevailing uptrend.

Technical Strength Behind the Rally

Several indicators support the bullish view:

• Breakout from inverted head-and-shoulders pattern

• Breakout from flag formation

• Rising trading volumes

• Trading above key moving averages

• Positive momentum indicators

Analysts believe sustained buying above breakout levels could pave the way for a move toward the ₹2,500 target.

Pharma Sector Attracts Investor Interest

The pharmaceutical sector has regained investor attention in recent months as global healthcare demand remains strong and export opportunities continue to expand.

Indian pharmaceutical companies are benefiting from increasing penetration into regulated markets, product diversification, and improving operational efficiencies.

Gland Pharma's technical breakout coincides with improving sentiment toward the broader healthcare sector, adding further support to the stock's outlook.

Viyash Scientific Breaks Out of Bullish Cup-and-Handle Pattern

CMP: ₹267

Target: ₹294

Stop Loss: ₹260

The second stock recommendation from HDFC Securities is Viyash Scientific, which has recently delivered a breakout from a bullish cup-and-handle pattern on the weekly chart.

The cup-and-handle formation is considered one of the strongest continuation patterns and often signals the beginning of a sustained upward move when accompanied by strong volume participation.

Indicators Suggest Momentum Is Building

Technical indicators supporting the stock include:

• Weekly breakout confirmation

• Strong volume participation

• RSI sustaining above 50

• MACD crossover into bullish territory

• Price trading above major moving averages

The combination of momentum and volume suggests growing investor confidence in the stock.

What Investors Should Watch Going Forward

Market participants are expected to closely monitor how the Nifty behaves around current support levels over the next few trading sessions.

A successful defense of the 23,630–23,800 support zone could improve sentiment and trigger fresh buying across sectors.

At the same time, stock-specific opportunities are likely to remain the dominant theme as investors focus on companies showing relative strength and favorable technical setups.

Strategy for Traders

Analysts recommend:

• Maintaining strict stop-loss discipline

• Focusing on fundamentally strong stocks

• Tracking support and resistance levels closely

• Avoiding excessive leverage during volatile sessions

• Using corrections selectively for accumulation

Outlook: Consolidation Before the Next Move?

The Indian market appears to be undergoing a healthy consolidation phase after a strong rally. While short-term volatility may persist, the broader trend remains positive unless critical support levels are breached.

Technical indicators suggest that the current correction could provide opportunities for investors willing to focus on quality stocks with strong momentum and improving earnings prospects.